Mutant p53 can either directly activate several CSC markers such as ALDHA1, CD44, and LGR5 to promote stemness [40] or can promote stemness indirectly by activating PI3K/AKT2-mediated integrin or growth factor receptor cycling, as reported in glioblastoma and breast cancer cells [9]. This evidence concerns the gene TP53 and breast cancer.